MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
HKD 5.37
(2.48%)
HKD 5.37
(2.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -152.99 Million | -107.67 Million | -44.21 Million | -9.57 Million | -17.95 Million |
| Net Income | -125.01 Million | -35.04 Million | -48.15 Million | -121.25 Million | -78.61 Million |
| Depreciation & Amortization | 11.17 Million | 10.48 Million | 8.33 Million | 5.48 Million | 3.43 Million |
| Deferred income taxes | - | - | 40.35 Million | -1.21 Million | -4.17 Million |
| Stock-based compensation | - | - | 12.43 Million | 111.17 Million | 57.56 Million |
| Change in working capital | 6.23 Million | -35.01 Million | -33.88 Million | -1.69 Million | 4.38 Million |
| Other non-cash items | -50.07 Million | -48.09 Million | -23.29 Million | -2.06 Million | -537 Thousand |
| Investing Cash Flow | -540.7 Million | -965.58 Million | 97.68 Million | -1.22 Million | -95.14 Million |
| Investments in PPE | -28.69 Million | -29.77 Million | -18.72 Million | -25.68 Million | -30.51 Million |
| Acquisitions | - | - | - | 28 Thousand | 1.94 Million |
| Investment purchases | - | -935.8 Million | - | -205.5 Million | -208.7 Million |
| Sales/Maturities of investments | - | - | 116.36 Million | 219.57 Million | 154.01 Million |
| Other Investing Activities | -512 Million | -936.22 Million | 45 Thousand | 10.36 Million | -11.88 Million |
| Financing Cash Flow | -23.46 Million | -20.57 Million | 1.57 Billion | 511.27 Million | 100.87 Million |
| Debt repayment | -560.57 Thousand | -356 Thousand | -173 Thousand | -20 Million | -725 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -22.9 Million | - | - | - | - |
| Common Stock Issuance | - | - | 1.65 Billion | 8.62 Million | - |
| Other Financing Activities | -23.46 Million | -20.21 Million | -83.03 Million | 522.65 Million | 101.6 Million |
| Accounts receivables | -27.19 Million | -24.18 Million | -18.64 Million | -3.16 Million | -3.35 Million |
| Accounts payables | - | 24.18 Million | 18.64 Million | 3.16 Million | 3.35 Million |
| Inventory | 21.69 Million | -35.41 Million | -16.28 Million | -9.89 Million | -2.08 Million |
| Other working capital | 11.72 Million | 396 Thousand | -17.59 Million | 8.19 Million | 6.46 Million |
| Cash at beginning of period | 1.08 Billion | 2.15 Billion | 539.8 Million | 41.42 Million | 53.46 Million |
| Cash at end of period | 365.43 Million | 1.08 Billion | 2.15 Billion | 539.8 Million | 41.42 Million |
| Capital Expenditure | -28.69 Million | -29.77 Million | -18.72 Million | -25.68 Million | -30.51 Million |
| Effect of forex changes on cash | -1.64 Million | 27.1 Million | -16.47 Million | -2.1 Million | 186 Thousand |
| Net cash flow / Change in cash | -718.81 Million | -1.06 Billion | 1.61 Billion | 498.37 Million | -12.03 Million |
| Free Cash Flow | -181.69 Million | -137.45 Million | -62.93 Million | -35.25 Million | -48.47 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.86 Million | -18.86 Million | -125.01 Million | -53.17 Million | -53.17 Million | -9.33 Million |
| Depreciation & Amortization | - | - | 11.17 Million | 4.75 Million | 4.58 Million | 830 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 6.23 Million | -2.74 Million | -2.74 Million | - |
| Other non-cash items | -19.45 Million | -19.45 Million | -50.07 Million | -9.43 Million | -9.26 Million | -7.39 Million |
| Investing Cash Flow | 101.79 Million | 101.79 Million | -540.7 Million | -55.79 Million | -55.79 Million | -214.55 Million |
| Investments in PPE | -20.9 Million | -20.9 Million | -28.69 Million | -12.33 Million | -12.33 Million | -2 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 122.69 Million | 122.69 Million | -512 Million | -43.45 Million | -43.45 Million | -212.54 Million |
| Financing Cash Flow | 2.77 Million | 2.77 Million | -23.46 Million | -11.59 Million | -11.59 Million | -141.5 Thousand |
| Debt repayment | - | - | -560.57 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -22.9 Million | -11.45 Million | -11.45 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.77 Million | 2.77 Million | -23.46 Million | -138.78 Thousand | -138.78 Thousand | -141.5 Thousand |
| Accounts receivables | - | - | -27.19 Million | -13.59 Million | -13.59 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 21.69 Million | 10.84 Million | 10.84 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 1.08 Billion | - | - | 1.21 Billion |
| Cash at end of period | 67.45 Million | 67.45 Million | 365.43 Million | -130.42 Million | -130.42 Million | 2.21 Billion |
| Capital Expenditure | -20.9 Million | -20.9 Million | -28.69 Million | -12.33 Million | -12.33 Million | -2 Million |
| Effect of forex changes on cash | 1.2 Million | 1.2 Million | -1.64 Million | -2.44 Million | -2.44 Million | 1.61 Million |
| Net cash flow / Change in cash | 67.45 Million | 67.45 Million | -718.81 Million | -130.42 Million | -130.42 Million | 995.6 Million |
| Free Cash Flow | -59.22 Million | -59.22 Million | -181.69 Million | -72.93 Million | -72.93 Million | -17.91 Million |
CAPFIN
7186
AMQFF
ACRI-A
SAE
MANJEERA